Tim-3 expression in human kidney allografts

Transplant Immunology

Volumn 17, Issue 3, 2007, Pages 215-222

  Ponciano, Viviane C ^a   Renesto, Paulo G ^a   Nogueira, Eliana ^a   Rangel, Érika B ^a   Cenedeze, Marcos A ^a   Franco, Marcello F ^a   Câmara, Niels O S ^a,b   Pacheco Silva, Alvaro ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute rejection; Kidney transplantation; Tim 3

Indexed keywords

FAS LIGAND; GAMMA INTERFERON; GRANZYME B; MESSENGER RNA; PERFORIN; PROTEIN; PROTEIN TIM 3; UNCLASSIFIED DRUG;

ARTICLE; CORRELATION ANALYSIS; CYTOTOXICITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ADULT; FAS LIGAND PROTEIN; FEMALE; GRAFT REJECTION; GRANZYMES; HUMANS; INTERFERON TYPE II; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROC CURVE; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 33847314185     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2006.11.003     Document Type: Article

References (25)

1. Curtis J.J. End-stage renal disease patients: referral for transplantation. J Am Soc Nephrol 9 12 Suppl (1998) S137-S140
2. Karam V.H., Gasquet I., Delvart V., Hiesse C., Dorent R., Danet C., et al. Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation. Transplantation 76 12 (2003) 1699-1704
3. Cosio F.G., Pelletier R.P., Falkenhain M.E., Henry M.L., Elkhammas E.A., Davies E.A., et al. Impact of acute rejection and early allograft function on renal allograft survival. Transplantation 63 11 (1997) 1611-1615
4. Hariharan S., Johnson C.P., Bresnahan B.A., Taranto S.E., McIntosh M.J., and Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342 9 (2000) 605-612
5. Meier-Kriesche H.U., Ojo A.O., Hanson J.A., Cibrik D.M., Punch J.D., Leichtman A.B., et al. Increased impact of acute rejection on chronic allograft failure in recent era. Transplantation 70 7 (2000) 1098-1100
6. D'elios M.M., Josien R., Manghetti M., Amedei A., de Carli M., Cuturi M.C., et al. Predominant Th1 cell infiltration in acute rejection episodes of human kidney grafts. Kidney Int 51 6 (1997) 1876-1884
7. Hall B.M. Cells mediating allograft rejection. Transplantation 51 6 (1991) 1141-1151
8. Pavlakis M., Lipman M., and Strom T.B. Intragraft expression of T-cell activation genes in human renal allograft rejection. Kidney Int 53 Suppl 1 (1996) S7-S12
9. Strehlau J., Pavlakis M., Lipman M., Shapiro M., Vasconcellos L., Harmon W., et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci U S A 94 2 (1997) 695-700
10. Strom T.B., and Suthanthiran M. Prospects and applicability of molecular diagnosis of allograft rejection. Semin Nephrol 20 2 (2000) 103-107
11. Li B., Hartono C., Ding R., Sharma V.K., Ramaswamy R., Qian B., et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 344 13 (2001) 947-954
12. Sabek O., Dorak M.T., Kotb M., Gaber A.O., and Gaber L. Quantitative detection of T-cell activation markers by real-time PCR in renal transplant rejection and correlation with histopathologic evaluation. Transplantation 74 5 (2002) 701-707
13. Simon T., Opelz G., Wiesel M., Ott R.C., and Susal C. Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am J Transplant 3 9 (2003) 1121-1127
14. Desvaux D., Schwarzinger M., Pastural M., Baron C., Abtahi M., Berrehar F., et al. Molecular diagnosis of renal allograft rejection: correlation with histopathologic evaluation and antirejection therapy resistance. Transplantation 78 50 (2004) 647-653
15. Salama A.D., Najafian N., Clarkson M.R., Harmon W.E., and Sayegh M.H. Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 14 6 (2003) 1643-1651
16. Schenk S., Kish D.D., He C., El-Sawy T., Chiffoleau E., Chen C., et al. Alloreactive T cell responses and acute rejection of single class II MHC-disparate heart allografts are under strict regulation by CD4+CD25+ T cells. J Immunol 174 6 (2005) 3741-3748
17. Monney L., Sabatos C.A., Gaglia J.L., Ryu A., Waldner H., Chernova T., et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415 6871 (2002) 536-541
18. Mcintire J.J., Umetsu S.E., Akbari O., Potter M., Kuchroo V.K., Barsh G.S., et al. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immunol 2 12 (2001) 1109-1116
19. Kuchroo V.K., Umetsu D.T., Dekruyff R.H., and Freeman G.J. The Tim gene family: emerging roles in immunity and disease. Nat Rev Immunol 3 6 (2003) 454-462
20. Noguchi E., Nakayama M., Kamioka K., Ichikawa K., Shibasaki M., and Arinami T. Insertion/Deletion coding polymorphisms in hHAVcr-1 are not associated with atopic asthma in the Japanese population. Genes Immun 4 2 (2003) 170-173
21. Sánchez-Fueyo A., Tian J., Picarella D., Domenig C., Zheng X.X., Sabatos C.A., et al. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 4 11 (2003) 1093-1101
22. Sabatos C.A., Chakravarti S., Cha E., Schubart A., Sanchez-Fueyo A., Zheng X.X., et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 4 11 (2003) 1102-1110
23. Khademi M., Illés Z., Gielen A., Marta M., Takazawa N., Baecher-Allan C., et al. T cell Ig- and mucin-domain-containing molecule-3 (Tim-3) and Tim-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J Immunol 172 11 (2004) 7169-7176
24. Zhu C., Anderson A.C., Shubart A., Xiong H., Imitola J., Khoury S.J., et al. Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6 12 (2005) 1245-1252
25. Racusen L.C., Solez K., Colvin R.B., Bonsib S.M., Castro M.C., Cavallo T., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 55 2 (1999) 713-723